Transplantation, AutologousLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, B-CellAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaRemission InductionMelphalanLymphoma, Non-HodgkinTransplantation, HomologousTreatment OutcomeVincristineTransplantation ConditioningAntibodies, Monoclonal, Murine-DerivedCyclophosphamideCombined Modality TherapyLymphoma, FollicularDoxorubicinProto-Oncogene Proteins c-bcl-6PrednisoneSalvage TherapyHodgkin DiseaseDisease-Free SurvivalStem CellsEtoposideGerminal CenterPrognosisRecurrenceCytarabineRetrospective StudiesMyeloablative AgonistsLymphomaSurvival RateSurvival AnalysisCarmustineBone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell MobilizationThiotepaBone Marrow PurgingChemotherapy-Induced Febrile NeutropeniaHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Mantle-CellWhole-Body IrradiationFatal OutcomeAmyloidosisHematopoietic Stem CellsBusulfanDexamethasoneBoronic AcidsB-LymphocytesPyrazinesFollow-Up StudiesTranslocation, GeneticLymphoproliferative DisordersGraft SurvivalEpstein-Barr Virus InfectionsLymphoma, B-Cell, Marginal ZoneAntineoplastic AgentsAntineoplastic Agents, AlkylatingCARD Signaling Adaptor ProteinsAntigens, CD34IfosfamideThalidomideAutograftsTime FactorsLiver TransplantationInduction ChemotherapyGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationPodophyllotoxinLeukapheresisImmunohistochemistryNeoplasm, ResidualLeukemia, Myeloid, AcuteMaintenance ChemotherapyTransplantation ChimeraTissue DonorsCord Blood Stem Cell TransplantationAntibodies, MonoclonalCell TransplantationIdarubicinMyelodysplastic SyndromesKidney TransplantationNeoplasms, Second PrimaryMitoxantroneEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsCell Line, TumorProspective StudiesCisplatinLeukemia, Plasma CellImmunosuppressive AgentsTumor Markers, BiologicalImmunophenotypingGene Expression ProfilingInfusions, Spinal